These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15847749)

  • 1. [Effect of hyperhomocysteinemia and methylenetetrahydrofolate reductase 677C --> T mutation in venous thromboembolism risk of young adults].
    Fernández-Miranda C; Coto A; Martínez J; Gómez P; Gómez de la Cámara A
    Med Clin (Barc); 2005 Apr; 124(14):532-4. PubMed ID: 15847749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinemia and methylenetetrahydrofolate reductase 677C-->T and 1298A-->C mutations in patients with inflammatory bowel disease.
    Fernández-Miranda C; Martínez Prieto M; Casis Herce B; Sánchez Gómez F; Gómez González P; Martínez López J; Sáenz-López Pérez S; Gómez de la Cámara A
    Rev Esp Enferm Dig; 2005 Jul; 97(7):497-504. PubMed ID: 16262529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The methylenetetrahydrofolate reductase polymorphism (MTHFR c.677C>T) and elevated plasma homocysteine levels in a U.S. pediatric population with incident thromboembolism.
    Joachim E; Goldenberg NA; Bernard TJ; Armstrong-Wells J; Stabler S; Manco-Johnson MJ
    Thromb Res; 2013 Aug; 132(2):170-4. PubMed ID: 23866722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion.
    Di Crecchio L; Parodi MB; Sanguinetti G; Iacono P; Ravalico G
    Ophthalmology; 2004 May; 111(5):940-5. PubMed ID: 15121372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of cancer: cross-sectional and prospective studies and meta-analyses of 75,000 cases and 93,000 controls.
    Zacho J; Yazdanyar S; Bojesen SE; Tybjærg-Hansen A; Nordestgaard BG
    Int J Cancer; 2011 Feb; 128(3):644-52. PubMed ID: 20473868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma homocysteine level and 677C-->T mutation on the MTHFR gene in patients with venous thromboembolism.
    Hanta I; Soydas Y; Karatasli M; Koseoglu Z; Satar S; Hasturk S
    Bratisl Lek Listy; 2010; 111(2):70-3. PubMed ID: 20429317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
    Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
    Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece.
    Zalavras ChG; Giotopoulou S; Dokou E; Mitsis M; Ioannou HV; Tzolou A; Kolaitis N; Vartholomatos G
    Int Angiol; 2002 Sep; 21(3):268-71. PubMed ID: 12384649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia in central retinal vein occlusion in young adults.
    Parodi MB; Di Crecchio L
    Semin Ophthalmol; 2003 Sep; 18(3):154-9. PubMed ID: 15513477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion.
    Weger M; Stanger O; Deutschmann H; Leitner FJ; Renner W; Schmut O; Semmelrock J; Haas A
    Am J Ophthalmol; 2002 Jul; 134(1):57-61. PubMed ID: 12095808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.
    Bezemer ID; Doggen CJ; Vos HL; Rosendaal FR
    Arch Intern Med; 2007 Mar; 167(5):497-501. PubMed ID: 17353498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.
    Mtiraoui N; Ezzidi I; Chaieb M; Marmouche H; Aouni Z; Chaieb A; Mahjoub T; Vaxillaire M; Almawi WY
    Diabetes Res Clin Pract; 2007 Jan; 75(1):99-106. PubMed ID: 16828193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of MTHFR c.677C>T on plasma homocysteine levels depends on health, age and smoking.
    Semmler A; Moskau S; Stoffel-Wagner B; Weller M; Linnebank M
    Clin Invest Med; 2009 Dec; 32(6):E310. PubMed ID: 20003837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The methylenetetrahydrofolate reductase (MTHFR) 677C-->T mutation and cardiovascular risk--A case of ischemic stroke and acute myocardial infarction.
    Melo M; Gaspar E; Madeira S; de Moura P; Alexandrino B; de Moura JJ
    Rev Port Cardiol; 2005 Jan; 24(1):89-99. PubMed ID: 15773669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of hyperhomocysteinemia in cerebral venous sinus thrombosis.
    Kalita J; Singh VK; Misra UK
    Indian J Med Res; 2020 Dec; 152(6):584-594. PubMed ID: 34145098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism associated with hyperhomocysteinemia, homozygosity for the methylenetetrahydrofolate reductase 677C>T gene variant, and secondary polycythemia.
    Masuda K; Imashuku S
    Blood Coagul Fibrinolysis; 2020 Jun; 31(4):270-273. PubMed ID: 32004198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate and severe hyperhomocysteinemia with thrombosis: a study of genetic determinants.
    Gaustadnes M; Rüdiger N; Rasmussen K; Ingerslev J
    Thromb Haemost; 2000 Apr; 83(4):554-8. PubMed ID: 10780316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study.
    Hsu TS; Hsu LA; Chang CJ; Sun CF; Ko YL; Kuo CT; Chiang CW; Lee YS
    Thromb Res; 2001 Jun; 102(5):387-95. PubMed ID: 11395124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and biochemical investigations of patients with intermediate or severe hyperhomocysteinemia.
    Sørensen JT; Gaustadnes M; Stabler SP; Allen RH; Mudd SH; Hvas AM
    Mol Genet Metab; 2016 Mar; 117(3):344-50. PubMed ID: 26750749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.